{"data":{"ModuleTitle":{"label":"Module Title","value":"Company Description"},"CompanyName":{"label":"Company Name","value":"Cardiff Oncology, Inc."},"Symbol":{"label":"Symbol","value":"CRDF"},"Address":{"label":"Address","value":"11055 FLINTKOTE AVENUE, SAN DIEGO, California, 92121, United States"},"Phone":{"label":"Phone","value":"+1 858 952-7570"},"Industry":{"label":"Industry","value":"Biotechnology: Biological Products (No Diagnostic Substances)"},"Sector":{"label":"Sector","value":"Health Care"},"Region":{"label":"Region","value":"North America"},"CompanyDescription":{"label":"Company Description","value":"Cardiff Oncology Inc is a clinical-stage, biotechnology company, developing treatment options for cancer patients in indications with the greatest medical need, including KRAS-mutated metastatic colorectal cancer, pancreatic cancer, metastatic castrate-resistant prostate cancer and leukemias."},"CompanyUrl":{"label":"Company Url","value":"https://www.cardiffoncology.com"},"KeyExecutives":{"label":"Key Executives","value":[{"name":"Fairooz Kabbinavar","title":"Chief Medical Officer"},{"name":"Mark Erlander","title":"Chief Executive Officer & Director"},{"name":"Tod Smeal","title":"Chief Scientific Officer"},{"name":"Vicki Kelemen","title":"Chief Operating Officer"}]}},"message":null,"status":{"rCode":200,"bCodeMessage":null,"developerMessage":null}}